Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ASTRAZENECA PHARMA ALKEM LABORATORIES/
ASTRAZENECA PHARMA
 
P/E (TTM) x 37.5 95.5 39.3% View Chart
P/BV x 6.5 22.7 28.8% View Chart
Dividend Yield % 1.0 0.3 336.6%  

Financials

 ALKEM LABORATORIES   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
ASTRAZENECA PHARMA
Mar-23
ALKEM LABORATORIES/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,6253,620 100.2%   
Low Rs2,8352,438 116.3%   
Sales per share (Unadj.) Rs970.1401.2 241.8%  
Earnings per share (Unadj.) Rs84.239.7 212.0%  
Cash flow per share (Unadj.) Rs110.246.2 238.3%  
Dividends per share (Unadj.) Rs50.0016.00 312.5%  
Avg Dividend yield %1.50.5 293.0%  
Book value per share (Unadj.) Rs756.4234.4 322.6%  
Shares outstanding (eoy) m119.5725.00 478.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.37.5 44.1%   
Avg P/E ratio x38.476.3 50.3%  
P/CF ratio (eoy) x29.365.5 44.7%  
Price / Book Value ratio x4.312.9 33.1%  
Dividend payout %59.440.3 147.4%   
Avg Mkt Cap Rs m386,20775,718 510.1%   
No. of employees `000NANA-   
Total wages/salary Rs m21,3142,591 822.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,99310,030 1,156.5%  
Other income Rs m2,161261 827.9%   
Total revenues Rs m118,15310,291 1,148.2%   
Gross profit Rs m15,0651,249 1,206.2%  
Depreciation Rs m3,104163 1,909.1%   
Interest Rs m1,0746 17,041.3%   
Profit before tax Rs m13,0481,341 973.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,980348 856.0%   
Profit after tax Rs m10,068993 1,014.0%  
Gross profit margin %13.012.5 104.3%  
Effective tax rate %22.826.0 88.0%   
Net profit margin %8.79.9 87.7%  
BALANCE SHEET DATA
Current assets Rs m86,0649,359 919.5%   
Current liabilities Rs m37,0714,844 765.3%   
Net working cap to sales %42.245.0 93.8%  
Current ratio x2.31.9 120.2%  
Inventory Days Days3349 65.9%  
Debtors Days Days6739 171.5%  
Net fixed assets Rs m37,2452,061 1,806.8%   
Share capital Rs m23950 478.2%   
"Free" reserves Rs m90,2085,811 1,552.3%   
Net worth Rs m90,4475,861 1,543.1%   
Long term debt Rs m00-   
Total assets Rs m124,54111,421 1,090.5%  
Interest coverage x13.2213.9 6.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 106.1%   
Return on assets %8.98.7 102.3%  
Return on equity %11.116.9 65.7%  
Return on capital %15.623.0 67.9%  
Exports to sales %14.60-   
Imports to sales %037.4 0.0%   
Exports (fob) Rs m16,916NA-   
Imports (cif) Rs mNA3,747 0.0%   
Fx inflow Rs m16,916612 2,764.1%   
Fx outflow Rs m4,1903,747 111.8%   
Net fx Rs m12,727-3,135 -406.0%   
CASH FLOW
From Operations Rs m16,825583 2,886.4%  
From Investments Rs m1,128181 623.1%  
From Financial Activity Rs m-17,608-245 7,192.9%  
Net Cashflow Rs m416519 80.2%  

Share Holding

Indian Promoters % 56.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 24.4 5.4 450.2%  
FIIs % 8.5 2.7 319.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 25.0 173.0%  
Shareholders   65,184 29,032 224.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs ASTRAZENECA PHARMA Share Price Performance

Period ALKEM LABORATORIES ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day -1.18% 0.01% 1.18%
1-Month -0.99% -3.61% -0.75%
1-Year 52.26% 59.20% 61.82%
3-Year CAGR 21.70% 20.50% 18.16%
5-Year CAGR 22.99% 22.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.